Mestre TA - Search Results

1

Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.

Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, Gonçalves N, Anderson KE, Cardoso F, Ferreira JJ, Mestre TA, Stout JC, Sampaio C. Landwehrmeyer GB, et al. Among authors: mestre ta. Mov Disord Clin Pract. 2016 Jun 22;4(2):212-224. doi: 10.1002/mdc3.12388. eCollection 2017 Mar-Apr. Mov Disord Clin Pract. 2016. PMID: 30363395 Free PMC article.

2

Putaminal petechial haemorrhage as the cause of non-ketotic hyperglycaemic chorea: a neuropathological case correlated with MRI findings.

Mestre TA, Ferreira JJ, Pimentel J. Mestre TA, et al. J Neurol Neurosurg Psychiatry. 2007 May;78(5):549-50. doi: 10.1136/jnnp.2006.105387. J Neurol Neurosurg Psychiatry. 2007. PMID: 17435197 Free PMC article. No abstract available.

3

A multimodal approach to physical therapy in Parkinson's disease: optimizing strategies.

Mestre T, Ferreira JJ, Jain S. Mestre T, et al. Mov Disord. 2009 Apr 30;24(6):946. doi: 10.1002/mds.22478. Mov Disord. 2009. PMID: 19224597 No abstract available.

4

Eslicarbazepine acetate: a new option for the treatment of focal epilepsy.

Mestre T, Ferreira J. Mestre T, et al. Expert Opin Investig Drugs. 2009 Feb;18(2):221-9. doi: 10.1517/13543780802635107. Expert Opin Investig Drugs. 2009. PMID: 19236268 Review.

5

Therapeutic interventions for disease progression in Huntington's disease.

Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C. Mestre T, et al. Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006455. doi: 10.1002/14651858.CD006455.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588392 Free PMC article. Review.

6

Therapeutic interventions for symptomatic treatment in Huntington's disease.

Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C. Mestre T, et al. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006456. doi: 10.1002/14651858.CD006456.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588393 Review.

7

Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.

Aziz NA, Jurgens CK, Landwehrmeyer GB; EHDN Registry Study Group; van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA. Aziz NA, et al. Neurology. 2009 Oct 20;73(16):1280-5. doi: 10.1212/WNL.0b013e3181bd1121. Epub 2009 Sep 23. Neurology. 2009. PMID: 19776381

8

Skin cancer and Parkinson's disease.

Ferreira JJ, Neutel D, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C. Ferreira JJ, et al. Mov Disord. 2010 Jan 30;25(2):139-48. doi: 10.1002/mds.22855. Mov Disord. 2010. PMID: 20063399 Free article. Review.

9

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.

Orth M; European Huntington's Disease Network; Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. Orth M, et al. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12. doi: 10.1136/jnnp.2010.209668. Epub 2010 Nov 19. J Neurol Neurosurg Psychiatry. 2011. PMID: 21097549 No abstract available.

10

Pharmacotherapy in Parkinson's disease: case studies.

Mestre T, Ferreira JJ. Mestre T, et al. Ther Adv Neurol Disord. 2010 Mar;3(2):117-26. doi: 10.1177/1756285609352366. Ther Adv Neurol Disord. 2010. PMID: 21179604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters